REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA
Clinical trials for REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to beat relapsed blood cancers
Disease control Recruiting nowThis study tests a new approach for adults with blood cancers like AML that have come back or not responded to treatment. Participants receive intense chemotherapy followed immediately by a donor stem cell transplant, plus drugs to prevent graft-versus-host disease. The goal is t…
Matched conditions: REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 17, 2026 06:17 UTC
-
New combo therapy aims to stop relapse in tough blood cancers
Disease control Recruiting nowThis study tests a new treatment for adults with aggressive blood cancers like acute myeloid leukemia (AML) that are hard to cure. Patients receive a combination of chemotherapy drugs (decitabine plus FLAG-Ida) and total body radiation, followed by a stem cell transplant from a h…
Matched conditions: REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:42 UTC